BioAtla, Inc. (BCAB)
4.40
-0.26
(-5.58%)
USD |
NASDAQ |
Apr 08, 10:01
BioAtla EPS Diluted (Quarterly) : -8.181 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.2719 |
| Actinium Pharmaceuticals, Inc. | -0.1904 |
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Annovis Bio, Inc. | -0.3964 |
| Azitra, Inc. | -0.208 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.784M |
| Revenue (Quarterly) | 2.00M |
| Total Expenses (Quarterly) | 11.78M |
| Enterprise Value | 10.95M |
| Gross Profit Margin (Quarterly) | 99.05% |
| Profit Margin (Quarterly) | -489.2% |
| Earnings Yield | -860.6% |
| Normalized Earnings Yield | -834.00 |